Abstract
The recent lifting of COVID-19 related restrictions in Switzerland causes uncertainty about the future of the epidemic. We developed a compartmental model for SARS-CoV-2 transmission in Switzerland and projected the course of the epidemic until the end of year 2020 under various scenarios. The model was age-structured with three categories, children (0-17), adults (18-64) and seniors (65- years). Lifting all restrictions according to the plans disclosed by the Swiss federal authorities by mid-May resulted in a rapid rebound in the epidemic, with the peak expected in July. Measures equivalent to at least 90% reduction in all contacts were able to eradicate the epidemic; 56% reduction in contacts could keep the intensive care unit occupancy under the critical level, and delay the next wave until October. Scenarios where strong contact reductions were only applied in selected age groups could not suppress the epidemic, increasing the risk of a next wave in July, and another stronger wave in September. Future interventions need to cover all age groups to keep the SARS-CoV-2 epidemic under control.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://gitlab.com/igh-idmm-public/covid-19/modelling_jestill
Funding Statement
This study was supported by the Swiss National Science Foundation (grant no 163878).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study uses only publicly available data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used for this project are collected from publicly available sources (see description in the manuscrpit, or the repository https://gitlab.com/igh-idmm-public/covid-19/modelling_jestill)
https://gitlab.com/igh-idmm-public/covid-19/modelling_jestill
